Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in patients with advanced, progressing hepatocellular carcinoma. N Engl J Med. 2018, 379(1):54-63. doi: 10.1056/NEJMoa1717002.
Advertisement
Articles by Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in patients with advanced, progressing hepatocellular carcinoma. N Engl J Med. 2018, 379(1):54-63. doi: 10.1056/NEJMoa1717002.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Medicaid MFN Pricing Could Save $8.6 Billion
2
Cardiology Prices Vary Widely by Insurer and State
3
CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks
4
Active US Drug Shortages Rise for Third Straight Quarter
5